The Guild Pharmacy Academy is partnering with Medtronic to develop a course for pharmacists about insulin pump therapy
The online course examines how insulin pump therapy works and how it can benefit people with type 1 diabetes.
Australia has one of the highest rates of type 1 diabetes in the world. In 2014, there were 2,509 new cases of type 1 diabetes in Australia, equating to 11 cases per 100,000 population or one in every 9,000 people.
Pharmacists provide an important role in the health of people with diabetes and with the changes in the distribution arrangement for insulin pump consumables, pharmacists now have a more involved role in supporting people who use insulin pump therapy, the Guild says.
Pharmacists have traditionally provided advice on multiple daily injection regimens for patients with type 1 diabetes.
But the recent changes to the distribution arrangements mean that the pharmacist can support and assist in the coordination of care and efficient use of insulin pumps, the Guild says.
Having an awareness of how insulin pumps work, the different consumables required and knowing when to refer patients to their diabetes healthcare team will assist in this coordination.
This course identifies the different components of an insulin pumps and how they work, describes the clinical benefits of insulin pump therapy to people with diabetes and identifies the more common problems users may experience with insulin pumps and their consumables.
This activity has been accredited for one hour of Group 1 CPD (or 1 CPD credit), suitable for inclusion in an individual pharmacist’s CPD plan, which can be converted to one hour of Group 2 CPD (or 2 CPD credits) upon successful completion of relevant assessment activities.
The Guild Pharmacy Academy has thanked Medtronic, manufacturers of the MiniMed 640G Insulin Pump, for their financial support and input of expertise in the development of this course.